Ann Intern Med

1. EGILMAN AC, Kesselheim AS, Sarpatwari A, Rome BN, et al
   Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label.
   Ann Intern Med. 2024 Apr 30. doi: 10.7326/M23-3212.
   

   >> Share

   
   

   
   BMC Cancer

2. WANG J, Tian C, Zheng BJ, Zhang J, et al
   The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer.
   BMC Cancer. 2024;24:549.
   

   >> Share

   
   
3. HAN JY, Che N, Mo J, Zhang DF, et al
   Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
   BMC Cancer. 2024;24:532.
   

   >> Share

   
   

   
   Br J Dermatol

4. MALLBRIS MJ, Jia B, Zhao Y, Kahlenberg JM, et al
   Concomitant Moderate to Severe Cutaneous Lesions Have Marked Impact on Quality of Life in Patients with Active Systemic Lupus Erythematosus: A Cross-Sectional Insight from Two Phase 3 Randomised Clinical Trials in Adults.
   Br J Dermatol. 2024 Apr 30:ljae183. doi: 10.1093.
   

   >> Share

   
   
5. HALIOUA B, Skayem C, Merhand S, Ben Hayoun Y, et al
   Long-term consequences on stigmatization and disease burden during adulthood among patients with childhood or adolescence-onset atopic dermatitis.
   Br J Dermatol. 2024 Apr 29:ljae176. doi: 10.1093.
   

   >> Share

   
   

   
   Cancer

6. KHATTAK MA, Luke JJ
   Top advances of the year: Melanoma.
   Cancer. 2024 Apr 29. doi: 10.1002/cncr.35354.
   

   >> Share

   
   
7. SATHISHKUMAR K, Sankarapillai J, Mathew A, Nair RA, et al
   Breast cancer survival in India across 11 geographic areas under the National Cancer Registry Programme.
   Cancer. 2024 Jan 6. doi: 10.1002/cncr.35188.
   

   >> Share

   
   
8. SMITH KL, Zhao F, Mayer IA, Tevaarwerk AJ, et al
   Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
   Cancer. 2024 Jan 18. doi: 10.1002/cncr.35187.
   

   >> Share

   
   

   
   Cancer Lett

9. SONG Y, Ren S, Chen X, Li X, et al
   Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics.
   Cancer Lett. 2024;590:216847.
   

   >> Share

   
   
10. LI K, Lin H, Liu A, Qiu C, et al
    SOD1-high fibroblasts derived exosomal miR-3960 promotes cisplatin resistance in triple-negative breast cancer by suppressing BRSK2-mediated phosphorylation of PIMREG.
    Cancer Lett. 2024;590:216842.
    

    >> Share

    
    

    
    Cancer Res

11. ZHENG SM, Feng YC, Zhu Q, Li RQ, et al
    MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer.
    Cancer Res. 2024 Apr 9:OF1-OF15. doi: 10.1158/0008-5472.CAN-23-3046.
    

    >> Share

    
    
12. BERNARD MJ, Goldstein AS
    A metabolic-epigenetic mechanism directs cell fate and therapeutic sensitivity in breast cancer.
    Cancer Res. 2024 Feb 8. doi: 10.1158/0008-5472.CAN-24-0460.
    

    >> Share

    
    
13. GEDIK ME, Saatci O, Oberholtzer N, Uner M, et al
    Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer.
    Cancer Res. 2024 Feb 6. doi: 10.1158/0008-5472.CAN-23-2812.
    

    >> Share

    
    

    
    Clin Dermatol

14. GRANT-KELS JM
    The Ethics of Full Body Skin Exams (FBSE).
    Clin Dermatol. 2024 Apr 30:S0738-081X(24)00073.
    

    >> Share

    
    

    
    Clin Exp Dermatol

15. GIL-PALLARES P, Gil-Pallares ME, Navarro-Bielsa A, Figueroa-Silva O, et al
    Tumor budding as a risk factor for lymph node metastases in cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
    Clin Exp Dermatol. 2024 Apr 30:llae155. doi: 10.1093.
    

    >> Share

    
    
16. AKUFFO-ADDO E, Samman L, Munawar L, Akbik M, et al
    Assessing GPT-4's Diagnostic Accuracy with Darker Skin Tones: Underperformance and Implications.
    Clin Exp Dermatol. 2024 May 2:llae158. doi: 10.1093.
    

    >> Share

    
    
17. TYRING S, Moore A, Morita A, Hong HC, et al
    Cedirogant in adults with psoriasis: a phase 2, randomized, placebo-controlled clinical trial.
    Clin Exp Dermatol. 2024 May 3:llae152. doi: 10.1093.
    

    >> Share

    
    
18. NAPOLITANO M, Foggia L, Patruno C, Gallo L, et al
    Efficacy of JAK inhibitors in the treatment of psoriasiform atopic dermatitis.
    Clin Exp Dermatol. 2024 May 3:llae162. doi: 10.1093.
    

    >> Share

    
    
19. OWENS KE, Zegeye Y, Pavlis M
    Characteristics and Outcomes of Clinical Primary Dermal Melanoma: A Case Series.
    Clin Exp Dermatol. 2024 May 3:llae163. doi: 10.1093.
    

    >> Share

    
    

    
    Cutis

20. OKWUNDU N, McMichael AJ
    Depression As a Potential Contributing Factor in Hidradenitis Suppurativa and Associated Racial Gaps.
    Cutis. 2024;113:137-140.
    

    >> Share

    
    
21. SALISBURY KR, Porter CL, Ali AK, Strowd LC, et al
    E-Consults in Dermatology: A Retrospective Analysis.
    Cutis. 2024;113:107-109.
    

    >> Share

    
    
22. CHOU P, Lee M, Elsensohn A
    Hyperkeratotic Nodule on the Knee in a Patient With KID Syndrome.
    Cutis. 2024;113:118-124.
    

    >> Share

    
    
23. BAKAYOKO A, Heath CR
    Papulosquamous Dermatophytid Reaction in a Child With Tinea Capitis.
    Cutis. 2024;113:E20-E21.
    

    >> Share

    
    
24. CHEN J, Kim T, Beatty CJ, Patton T, et al
    Eosinophilic Pustular Folliculitis in the Setting of Untreated Chronic Lymphocytic Leukemia.
    Cutis. 2024;113:E22-E24.
    

    >> Share

    
    

    
    Int J Cancer

25. LUFTNER D, Schuetz F, Schneeweiss A, Hartkopf A, et al
    Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
    Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34912.
    

    >> Share

    
    
26. KREGTING LM, Vrancken Peeters NJMC, Clarijs ME, Koppert LB, et al
    Health utility values of breast cancer treatments and the impact of varying quality of life assumptions on cost-effectiveness.
    Int J Cancer. 2024 Mar 13. doi: 10.1002/ijc.34899.
    

    >> Share

    
    

    
    Int J Dermatol

27. YAO A, Wang L, Qi F, Li J, et al
    Risk factors and early detection of joint damage in patients with psoriasis: a case-control study.
    Int J Dermatol. 2024 Apr 29. doi: 10.1111/ijd.17212.
    

    >> Share

    
    
28. ALEXIS A, Del Rosso JQ, Forman S, Martorell A, et al
    Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation.
    Int J Dermatol. 2024 Apr 29. doi: 10.1111/ijd.17189.
    

    >> Share

    
    
29. AQUINO JMRM, Guevara BEK
    Erythematous, annular lesions on the extremities of a female patient.
    Int J Dermatol. 2024;63:588-589.
    

    >> Share

    
    
30. JOHNSEN N, Poppens M, Cheng K
    Acne excoriee: Diagnostic overview and management.
    Int J Dermatol. 2024;63:565-571.
    

    >> Share

    
    
31. HWANG E, Lee T, Okifo K, Murphy M, et al
    Retrospective assessment of immunologic and histologic heterogeneity in granuloma annulare by cytokine staining.
    Int J Dermatol. 2024;63:655-659.
    

    >> Share

    
    
32. QIAO R, Zhu J, Liu Y, Zhao X, et al
    Refractory alopecia areata with single hairs imitating frontal fibrosing alopecia: a prospective observational study.
    Int J Dermatol. 2024;63:618-623.
    

    >> Share

    
    
33. EL-DOMYATI M, Moftah NH, Ahmed AM, Ibrahim MR, et al
    Evaluation of microneedling depth of penetration in management of atrophic acne scars: a split-face comparative study.
    Int J Dermatol. 2024;63:632-638.
    

    >> Share

    
    
34. KIPTIS PK, Mirembe SK, Aloyomola G, Mulyowa GK, et al
    Pityriasis rosea: dermoscopic features in Uganda.
    Int J Dermatol. 2024;63:611-617.
    

    >> Share

    
    
35. JIIRASUTAT N, Pongchareon P, Weschawalit S
    Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis.
    Int J Dermatol. 2024;63:572-579.
    

    >> Share

    
    
36. XU W, Zhang L, Song X
    Exploring the link between gut microbiota and alopecia areata: a two-sample Mendelian randomization analysis.
    Int J Dermatol. 2024;63:597-603.
    

    >> Share

    
    
37. TAKAHASHI KH, Utiyama TO, Bagatin E, Picosse FR, et al
    Efficacy and safety of botulinum toxin for rosacea with positive impact on quality of life and self-esteem.
    Int J Dermatol. 2024;63:590-596.
    

    >> Share

    
    
38. BAREI F, Belotti A, Bortoluzzi P, Mattioli MA, et al
    Dermoscopic features of dermal duct tumors.
    Int J Dermatol. 2024;63:668-670.
    

    >> Share

    
    
39. BETTOLINI L, Alessandro F, Bighetti S, Incardona P, et al
    A new case of amyloid elastosis - dermoscopic findings and literature review.
    Int J Dermatol. 2024;63:679-681.
    

    >> Share

    
    
40. DIAZ MJ, Haq Z, Abdi P, Tran JT, et al
    New-onset depression and anxiety in adults with pyoderma gangrenosum: A case-control study with propensity score matching.
    Int J Dermatol. 2024;63:e95-e97.
    

    >> Share

    
    
41. GU Y, Sebaratnam DF
    GLP-1 receptor agonists for hidradenitis suppurativa: Navigating benefits, risks, and ethical considerations.
    Int J Dermatol. 2024;63:e100-e101.
    

    >> Share

    
    
42. GAAL M
    Microbotox for facial redness.
    Int J Dermatol. 2024;63:553-554.
    

    >> Share

    
    
43. HU Z, Zhao M
    The gut microbiota in alopecia areata: Potential predictive biomarkers and therapy targets?
    Int J Dermatol. 2024;63:555-556.
    

    >> Share

    
    
44. METIN Z, Akca HM, Tur K, Akogul S, et al
    Intersecting pathways: evaluating inflammatory markers and metabolism in chronic spontaneous urticaria with a multi-marker approach.
    Int J Dermatol. 2024;63:604-610.
    

    >> Share

    
    
45. KEMENY L
    Editor's Highlights - May 2024.
    Int J Dermatol. 2024;63:551-552.
    

    >> Share

    
    

    
    Intern Med

46. SUZUKI S, Suzuki K, Furukawa T, Nakajima M, et al
    Past Endemic Izumi Fever or Yersinia pseudotuberculosis Infection Reappears Sporadically.
    Intern Med. 2024;63:1317-1322.
    

    >> Share

    
    
47. ANDOU M, Tominaga M, Nishikomori R, Gotoh K, et al
    STAT1 Mutations in Chronic Mucocutaneous Candidiasis Diagnosed in an Adult.
    Intern Med. 2024;63:1269-1271.
    

    >> Share

    
    

    
    J Cutan Pathol

48. IBRAHEIM MK, North JP
    Utility of IL-36 immunostaining in distinguishing psoriasis from pityriasis rosea and pityriasis lichenoides.
    J Cutan Pathol. 2024 Apr 30. doi: 10.1111/cup.14633.
    

    >> Share

    
    
49. BROOKS VT, Talty R, Marion A, Caron M, et al
    Cutaneous myxoid spindle cell squamous cell carcinoma.
    J Cutan Pathol. 2024 May 2. doi: 10.1111/cup.14636.
    

    >> Share

    
    
50. HASSAB-EL-NABY HMM, Rageh MA, El-Khalawany M
    Lichen planus follicularis tumidus in a patient with a history of hepatitis C.
    J Cutan Pathol. 2024 May 2. doi: 10.1111/cup.14634.
    

    >> Share

    
    
51. LIU SS, Park L, Karim R, Serralta V, et al
    Primary localized cutaneous lichen myxedematosus with light chain-restricted plasma cells: A distinct variant of the localized form of lichen myxedematosus.
    J Cutan Pathol. 2024 May 3. doi: 10.1111/cup.14624.
    

    >> Share

    
    

    
    J Dermatol

52. MINAMI Y, Shinkuma S, Yokoyama T, Shinoda S, et al
    A case of generalized pustular psoriasis complicated with SLE successfully treated with spesolimab.
    J Dermatol. 2024 Apr 28. doi: 10.1111/1346-8138.17243.
    

    >> Share

    
    
53. SATO M, Yamamoto T
    Cutaneous manifestations of adult-onset Still's disease: A comparative study between young-onset and elderly-onset groups.
    J Dermatol. 2024 Apr 29. doi: 10.1111/1346-8138.17235.
    

    >> Share

    
    
54. MAENG JE, Son SW, Lee SJ, Kim JC, et al
    Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression.
    J Dermatol. 2024;51:722-726.
    

    >> Share

    
    
55. WATANABE Y, Nobeyama Y, Asahina A
    A case of postoperative pyoderma gangrenosum on penis caused by patient himself.
    J Dermatol. 2024;51:e154-e155.
    

    >> Share

    
    
56. WAKI Y, Nobeyama Y, Chujo S, Asahina A, et al
    Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange.
    J Dermatol. 2024;51:e149-e150.
    

    >> Share

    
    
57. MATSUO M, Niwa H, Koga H, Ishii N, et al
    A case of paraneoplastic pemphigus associated with follicular lymphoma positive only for anti-desmoglein 3 antibody.
    J Dermatol. 2024;51:e164-e165.
    

    >> Share

    
    
58. OGURA Y, Kondo S, Suzuki T, Otsuka M, et al
    DiGeorge syndrome presenting with palmoplantar pustules: Comparative analysis of serum IL-22, NETs and IL-8 with usual palmoplantar pustulosis.
    J Dermatol. 2024;51:731-734.
    

    >> Share

    
    
59. SHIMOMURA-ISHIHARA M, Takeichi T, Noda T, Koizumi H, et al
    Natal teeth, hypoplasia of the first toe, and growth retardation in a patient with severe epidermolysis bullosa simplex.
    J Dermatol. 2024;51:e175-e177.
    

    >> Share

    
    
60. PASCOLINI G, Di Zenzo G, Morani P, Didona B, et al
    Ectoderm-derived findings in Ayme-Gripp syndrome.
    J Dermatol. 2024;51:e162-e163.
    

    >> Share

    
    
61. MIYAMOTO J, Kawashima Y, Hayakawa M, Fusumae T, et al
    Successful treatment of onychomatricoma with minimally invasive surgical procedures based on its pathogenesis: A case report.
    J Dermatol. 2024;51:719-721.
    

    >> Share

    
    
62. PIZZICHETTA MA, Polesel J, Perrot JL, Rubegni P, et al
    The combination of dermoscopy and reflectance confocal microscopy increases the diagnostic confidence of amelanotic/hypomelanotic lentigo maligna.
    J Dermatol. 2024;51:714-718.
    

    >> Share

    
    
63. CHOI S, Kwon SH, Sim WY, Lew BL, et al
    Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy.
    J Dermatol. 2024;51:684-690.
    

    >> Share

    
    
64. TAO S, Cao P, Jin M, Suo P, et al
    Integrated analysis of long non-coding RNAs and mRNAs associated with condyloma acuminatum.
    J Dermatol. 2024;51:671-683.
    

    >> Share

    
    
65. FUSHIDA N, Horii M, Fujii K, Mizumaki K, et al
    Clinical features of patients with connective tissue disease with anti-human upstream binding factor antibodies: A single-center retrospective study.
    J Dermatol. 2024;51:704-713.
    

    >> Share

    
    
66. IM D, Ueda K, Niwa H, Tanaka K, et al
    Low pH condition impairs BP-IgG binding to the basement membrane zone.
    J Dermatol. 2024;51:643-648.
    

    >> Share

    
    
67. GRAM SB, Brusgaard K, Bygum A, Christensen AH, et al
    Plantar keratoderma and curly hair as a diagnostic clue of cardiomyopathy risk.
    J Dermatol. 2024;51:e143-e144.
    

    >> Share

    
    
68. SHI Y, Wan S, Song X
    Role of neurogenic inflammation in the pathogenesis of alopecia areata.
    J Dermatol. 2024;51:621-631.
    

    >> Share

    
    

    
    J Invest Dermatol

69. MONTANO E, Tapia A, Howell MD, Ostojic J, et al
    Comparison of Tape-Stripping Platforms as Non-Invasive Solutions for Skin Biomarker Discovery.
    J Invest Dermatol. 2024 Apr 30:S0022-202X(24)00356.
    

    >> Share

    
    
70. JOHNSTON LA, Nagalla RR, Li M, Whitley SK, et al
    IL-17 Control of Cutaneous Immune Homeostasis.
    J Invest Dermatol. 2024 Apr 26:S0022-202X(23)03191.
    

    >> Share

    
    
71. GANIER C
    Unlocking Skin's Symphony: Single-Cell and Spatial Transcriptomics Reveal the Harmonious Interplay among Diverse Cell Populations.
    J Invest Dermatol. 2024 Apr 26:S0022-202X(24)00282.
    

    >> Share

    
    
72. XIONG S, Liu F, Sun J, Gao S, et al
    Abrogation of USP9X is a potential strategy to decrease PEG10 levels and impede tumor progression in cutaneous T-cell lymphoma.
    J Invest Dermatol. 2024 Apr 25:S0022-202X(24)00307.
    

    >> Share

    
    

    
    J Laryngol Otol

73. GONZALEZ-ESLAIT FJ, Blanco-Sarmiento PA, Bejarano-Dominguez K, Barreto JM, et al
    Tracing of Helicobacter pylori in the middle ear and mastoid mucosa of patients under 18 years of age with chronic otitis (with and without cholesteatomas).
    J Laryngol Otol. 2023 Oct 2:1-17. doi: 10.1017/S002221512300169.
    

    >> Share

    
    
74. MACCARRONE F, Cantaffa C, Genovese M, Tassi S, et al
    Fusion CT-MRI scans for pre-operative staging of Congenital Middle Ear Cholesteatoma.
    J Laryngol Otol. 2023 Nov 17:1-18. doi: 10.1017/S0022215123002001.
    

    >> Share

    
    

    
    Lancet

75. DE SOUZA IC, Langer FW
    Post-radiation angiosarcoma of the breast in a patient with a history of invasive ductal carcinoma.
    Lancet. 2024;403:1681-1682.
    

    >> Share

    
    
76. EARL HM
    Safe de-escalation of chemotherapy in HER2-positive early breast cancer.
    Lancet. 2024 Apr 3:S0140-6736(24)00535-X. doi: 10.1016/S0140-6736(24)00535.
    

    >> Share

    
    
77. PEREZ-GARCIA JM, Cortes J, Ruiz-Borrego M, Colleoni M, et al
    3-year invasive disease-free survival with chemotherapy de-escalation using an (18)F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
    Lancet. 2024 Apr 3:S0140-6736(24)00054-0. doi: 10.1016/S0140-6736(24)00054.
    

    >> Share

    
    

    
    Mycoses

78. MILANEZ EPR, de Souza PFSM, Monteiro RC, Pereira LMG, et al
    Fusarium keratitis in a Brazilian tropical semi-arid area: Clinical-epidemiological features, molecular identification and antifungal susceptibility.
    Mycoses. 2024;67:e13728.
    

    >> Share

    
    

    
    Nat Rev Cancer

79. SHEPARD HM
    Trastuzumab: dreams, desperation and hope.
    Nat Rev Cancer. 2024;24:287-288.
    

    >> Share

    
    

    
    PLoS One

80. KIM BK, Kim B, You SH, Jang MS, et al
    Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging.
    PLoS One. 2024;19:e0300171.
    

    >> Share

    
    
81. 
    Editorial Note: Cutaneous Squamous Cell Carcinoma (SCC) and the DNA Damage Response: pATM Expression Patterns in Pre-Malignant and Malignant Keratinocyte Skin Lesions.
    PLoS One. 2024;19:e0303120.
    

    >> Share

    
    
82. PATEL S, Armbruster H, Pardo G, Archambeau B, et al
    Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: A real-world single-center retrospective review.
    PLoS One. 2024;19:e0297531.
    

    >> Share

    
    
83. OGRIN R, Rushford MA, Fallon J, Mannix R, et al
    Describing the development and implementation of a novel collaborative multidisciplinary approach to deliver foot health supports for individuals experiencing homelessness and its outcomes.
    PLoS One. 2024;19:e0302572.
    

    >> Share

    
    
84. LUKASIEWICZ-SMIETANSKA D, Godlewski D, Nowakowska E, Szpak A, et al
    Association of the bitter taste genes TAS2R38 and CA6 and breast cancer risk; a case-control study of Polish women in Poland and Polish immigrants in USA.
    PLoS One. 2024;19:e0300061.
    

    >> Share

    
    
85. JOHN FA, Criollo V, Gaghan C, Armwood A, et al
    Immunization of turkeys with Clostridium septicum alpha toxin-based recombinant subunit proteins can confer protection against experimental Clostridial dermatitis.
    PLoS One. 2024;19:e0302555.
    

    >> Share

    
    
86. EVYANA D, Novianto E, Budianti WK, Krisanti RIA, et al
    Association between the severity of hard-to-treat psoriasis and the prevalence of metabolic syndrome: A hospital-based cross-sectional study in Jakarta, Indonesia.
    PLoS One. 2024;19:e0302391.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share